Global Tech Industries Group, INC.: insider trades · United States · SEC (Form 4)

About Global Tech Industries Group, INC.

Global Tech Industries Group, Inc. (ticker GTII) is a U.S.-incorporated issuer organized under the laws of Nevada, with business/address disclosures in SEC filings pointing to 511 Sixth Avenue, Suite 800, New York, New York 10011, United States. Based on the SEC materials reviewed, the company should not be described as a mainstream NYSE or NASDAQ operating company; rather, it appears as a thinly followed microcap/OTC-style issuer with limited visibility and a notably elevated risk profile. Its SEC classification has referenced services/management-services activity (SIC 8741), which is consistent with a holding-company or transitional corporate profile rather than a mature, single-line operating business. ([sec.gov](https://www.sec.gov/Archives/edgar/data/356590/0001641172-25-002022-index.htm)) Historically, GTII has pursued a transaction-driven strategy. In 2021, the company executed a stock purchase agreement to acquire Bronx Family Eye Care, Inc., showing a willingness to build through targeted acquisitions rather than organic platform development alone. In January 2025, GTII announced an agreement and plan of merger involving AIversity LLC, doing business as Traders GPT, with the issuance of preferred stock as merger consideration. Taken together, these disclosures indicate a corporate strategy centered on restructurings, acquisitions, and business combinations, where execution risk and financing capacity are central variables. ([sec.gov](https://www.sec.gov/Archives/edgar/data/356590/000149315221008057/ex10-1.htm)) Recent public filings also show that GTII has been operating under significant legal and governance pressure. In 2025, SEC-filed disclosures referenced the appointment of a court receiver in Nevada and subsequent court actions restricting the transfer of a large block of shares. For investors, that is a material point because such developments can impact share liquidity, control dynamics, corporate decision-making, and the feasibility of strategic transactions. ([sec.gov](https://www.sec.gov/Archives/edgar/data/356590/000164117225014507/form8-k.htm?utm_source=openai)) On business lines and competitive positioning, there is no strong public evidence of a broad, established product portfolio comparable to a scaled technology group listed on NYSE or NASDAQ. Instead, GTII appears to be a reconfiguring public vehicle with exposure to acquired businesses and project-level initiatives that have, at times, touched healthcare-related assets and digital/technology themes. For French-speaking investors, the right frame is therefore speculative restructuring optionality rather than stable operating fundamentals. In short, GTII is best understood as a U.S. corporate situation in flux, where recent legal events and merger activity matter at least as much as headline business descriptions. ([sec.gov](https://www.sec.gov/Archives/edgar/data/356590/000149315221008057/ex10-1.htm))